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CThe stem cell niche: a new target in medicine
Cosimo De Bari, Sarah Pringle, Costantino Pitzalis and Francesco Dell’AccioPurpose of review
Stem cells have a critical role in tissue homeostasis and
repair throughout life. Their fate between self-renewal and
differentiation is regulated by stem cell intrinsic
determinants and by signals from a specialized
microenvironment, the stem cell niche. Here, we focus on
recent progress in the anatomical and molecular
characterization of mammalian stem cell niches.
Recent findings
The location of stem cell niches in adult life is well known for
some tissues such as bone marrow, skin and gut. Physical
interactions with niche cells, orientation of the cleavage
plane during stem cell mitosis, and molecular cross talk at
the niche sites with involvement of the Wnt, Notch and bone
morphogenetic protein pathways control the balance
between symmetric and asymmetric division of stem cells
and related cell fate specification outcomes. A deregulation
in the control of these events in excess or in defect could
lead to either poor tissue homeostasis/repair or to tumor
formation.
Summary
The vibrant interest in stem cell niches and their molecular
regulation arises from the exciting potential to influence
stem cell functions in modern medicine. In the near future,
targeting stem cell niches could be a cell-free strategy to
achieve tissue repair and to re-establish tissue
homeostasis.
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Stem cells persist in most tissues in adult life and are
thought to contribute to tissue homeostasis and repair.
On a single-cell basis, they have the capacity to self-
renew (that is, to produce more stem cells) and to
differentiate into mature cell lineages [1]. Stem cell
self-renewal and differentiation appear to be regulated
by stem cell intrinsic determinants as well as by signals
from a specialized nurturing microenvironment called
‘stem cell niche’. The niche provides molecular signals
that participate in regulating stem cell activity to ensure
tissue homeostasis and repair while preserving a constant
pool of stem cells.
Pioneering studies on the gonadal niches in invertebrates
[2–4] have inspired a great deal of science in mammalian
systems with spectacular advance in our knowledge in the
last few years. In this article, we review recent progress in
the anatomical and molecular characterization of mam-
malian stem cell niches (Fig. 1).
The bone marrow hematopoietic stem cell
niches
The bone marrow hematopoietic stem cells (HSCs) are
the best-characterized adult stem cells and have been
purified to clinical grade close to homogeneity. Yet, only
recently, several studies have shed light on their
niche(s). Primitive HSCs are located close to the endo-
steal surface of trabecular bone and a subset of endosteal
osteoblasts provide niche signaling [5,6]. The role of
osteoblasts in regulating HSC number has been demon-
strated by studies showing that mutant mice with
expanded trabecular bone and increased numbers of
osteoblasts exhibit concomitant proportionate increases
in marrow HSCs without changes in committed progeni-
tor populations [5,6]. Conversely, conditional ablation of
osteoblasts in mice results in a reversible decrease in the
number of marrow HSCs [7], indicating that osteoblasts
are required for the maintenance of marrow HSCs. A
possible mechanism by which osteoblasts regulate the
number of HSCs is through secretion of osteopontin, a
bone matrix glycoprotein that appears to maintain HSC
quiescence and to negatively regulate HSC proliferation
and activity [8,9].
The molecular cross talk at the interface between the
niche osteoblasts and the adjacent HSCs is now a key area
of investigation due to its therapeutic potential to control
bone marrow HSCs. A complex paracrine signaling net-
work is emerging. Kit ligand is expressed by osteoblastsrized reproduction of this article is prohibited.
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Figure 1 Stem cell niches
Three different stem cell niches are shown. (a) The endosteal niche of hematopoietic stem cells (HSCs) in the bone marrow. HSCs are located close to
the endosteal surface of trabecular bone (TB) and a subset of endosteal osteoblasts are part of the niche. When the contact between osteoblasts and
HSCs is lost, HSCs activate and differentiate towards blood lineages. (b) In the small intestine, stem cells reside near the base of each crypt, depicted
here as a tube of cells. Intestinal stem cells give rise to four different progeny: Paneth cells, enteroendocrine cells, goblet cells, and absorptive
enterocytes. The crypt epithelium is separated by a basal lamina (BL) that is surrounded externally by mesenchyme. The mesenchymal cells emit signals
that participate in regulating stem cell activity. (c) In the skin, hair follicle stem cells reside in the ‘bulge’ region, located below the sebaceous gland (SG)
and at the juncture of the erector pili muscle. The follicle is surrounded by a basement lamina (BL), which in turn is surrounded by a dermal sheath. Bulge
stem cells give rise to transit-amplifying matrix cells, which proliferate and then differentiate to produce the hair shaft and the channel that surrounds it.
Matrix cells are surrounded by a pocket of specialized mesenchymal cells, the derma papilla (DP). Nerve fibers (NFs) innervate the epidermis (Ep) and
the bulge, and blood vessels (BVs) provide nutrients. Adapted from Fuchs et al. [1].and is able to activate Kit on the cell surface of HSCs [10].
The Notch ligand Jagged1 is also expressed by osteo-
blasts while Notch1 is activated in HSCs, thus suggesting
the involvement of the Notch signaling pathway in the
modulation of HSCs by osteoblasts [6]. Indeed, there is
evidence that Notch signaling would repress differen-
tiation programs in HSCs thereby facilitating HSC com-
petence to Wnt-induced proliferation [11,12]. Another
important interaction is between the ligand angiopoietin-
1 at the osteoblast surface with the receptor Tie-2
expressed on HSCs, shown to modulate HSC quiescence
and adhesion to the endosteal niche via N-cadherin
expression [13].
The cross talk at the niche could contribute to regulating
expression and activity of mediators of HSC quiescence/
self-renewal such as bmi-1 [14], p21 [15], p18 [16], and
the Ets transcription factor MEF/ELF4 [17], or lead to
inhibition of glycogen synthase kinase-3 (GSK-3),
recently shown to maintain HSCs while expanding the
progenitor pool [18].
Intriguingly, HSCs express a calcium-sensing receptor
that gives them the ability to sense and respond to
calcium concentrations. HSCs lacking this receptor show
decreased homing to the endosteal niche, suggesting a
role of bone mineral gradients in the lodgment andopyright © Lippincott Williams & Wilkins. Unauthretention of HSCs [19]. An unanticipated player in
the process of signal integration within the niche is the
sympathetic nervous system, which appears to regulate
the attraction of HSCs to their niche [20]. Adrenergic
signals control granulocyte colony-stimulating factor (G-
CSF)-induced osteoblast suppression and bone CXCL12
downregulation, leading to HSC egress into the circula-
tion [20]. CXCL12 is indeed highly expressed in bone
tissues and is believed to be critical for the attraction and
retention of HSCs to their niches [21].
The recent finding that CD150 expressing HSCs are
more abundant in the perivascular area of sinusoids than
at the endosteal site [22] points to the perivascular area
being a potential niche site for HSCs within the bone
marrow. Indeed, marrow sinusoidal endothelial cells
express cytokines such as CXCL12 and adhesion mol-
ecules such as E-selectin and vascular cell adhesion
molecule 1 that are important for HSC mobilization,
homing and engraftment [23,24]. Since the fenestrated
sinusoidal endothelium allows flow of blood-borne factors
across its wall, the association of HSCs with sinusoids
would ensure maintaining homeostatic blood cell pro-
duction and enabling prompt responses to hematological
stresses. Studies are now awaited to investigate whether
the perivascular and endosteal sites represent distinctive
specialized niches for different HSC subsets or if theorized reproduction of this article is prohibited.
C400 Basic scienceperivascular area is simply a stopover for HSCs en route
to circulation.
The small intestinal stem cell niche
Multipotent intestinal stem cells (ISCs) reside in a ring
about four cell diameters from the bottom of the crypt
of Lieberku¨hn, a finger-like invagination of the epi-
thelium into the underlying mesenchyme at the base
of the villus in the small intestine, and differentiate to
give rise to the absorptive enterocytes and to three types
of secretory cells: goblet, enteroendocrine, and Paneth
cells. While Paneth cells complete their differentiation
at the crypt base, the other three epithelial lineages
migrate from the crypt towards the tips of adjacent villi
and differentiate. Asymmetric cell division of ISCs,
proliferation of transit-amplifying cell progenies, distinct
migratory patterns, specific differentiation programs,
and correct positional information are all necessary for
the rapid homeostatic renewal of the villus structure [25].
The mesenchyme surrounding the epithelial crypt is
thought to be a main source of signals mediating differ-
ent cell fates along the crypt axis. The canonical Wnt
pathway plays a key role in the maintenance of ISCs and
in the modulation of their activity and is able to induce
cell-type-specific gene expression programs [26,27]. A
Wnt gradient is suggested by the distribution of nuclear
versus cytoplasmic b-catenin along the epithelium of
crypts and villi [25]. Canonical Wnt signaling also
ensures proper cell positioning in the intestinal epi-
thelium through the EphB/ephrinB system [28]. Genetic
studies also implicate Notch signaling in the mainten-
ance of ISCs and in ensuring proper cell-fate speci-
fications in the transit-amplifying cell compartment
[29,30]. Thus, ISCs are regulated by Wnt and Notch
signaling according to combinatorial rules that are similar
to those that operate in the bone marrow for the regu-
lation of HSCs.
The bone morphogenetic protein (BMP) signaling path-
way functions as a negative regulator of ISC proliferation.
Conditional deletion of the BMP receptor type IA in
epithelial cells results in expansion of the ISC population
[31]. Inhibition of BMP signaling by transgenic over-
expression of the BMP inhibitor Noggins leads to the
formation of numerous ectopic crypt-like structures [32].
Another player in the regulation of crypt cell activity is
glucagon-like peptide 2 (GLP-2). GLP-2 is produced by
enteroendocrine cells, which sense the nutrient environ-
ment in the gut lumen, and stimulates production of
enterocytes, which conversely absorb nutrients [33].
Intriguingly, the GLP-2 receptor is expressed not in
the crypt epithelium but in a subset of enteric neurons,
which therefore are postulated to fulfil a messenger role
between the GLP-2 signal and the epithelial target cells
[34]. Thus, as in the HSC endosteal niche, the nervousopyright © Lippincott Williams & Wilkins. Unauthosystem, which has the ability to integrate information
throughout the organism, may modulate stem cell niche
functions in the gut.
The hair follicle stem cell niche
In the skin there are two types of stem cells. The stem
cell in the basal layer of the epidermis is responsible for
the renewal of the stratified epidermis, while the hair
follicle stem cell (HFSC), which resides in the ‘bulge’
region located below the sebaceous gland and at the
juncture of the erector pili muscle, is responsible for
the regeneration of hair and sebaceous glands [35].
Initially, it was thought that bulge stem cells were also
providing homeostatic replenishment to the epidermis.
Recent evidence, however, indicates that bulge HFSCs
are not required for physiological epidermal homeostasis,
although during wound healing they can contribute to
epidermal regeneration and repair [36,37]. Thus, epi-
dermal basal cells and bulge HFSCs appear to be distinct
stem cell populations.
In the early 1990s it was discovered that label-retaining,
quiescent cells are located in the bulge region [38], but
only recently mouse transgenic strategies have allowed
prospective isolation of viable HFSC populations for
functional analysis and genetic profiling [39–42]. As in
the ISC niche, the Wnt signaling pathway plays a crucial
role in the hair follicle system, affecting all phases of stem
cell activity, from quiescence to proliferation, fate deter-
mination and terminal differentiation [43].
Using tissue-specific and inducible loss-of-function strat-
egies in mice it has been shown that ablation of Notch1
during embryonic development does not perturb forma-
tion and patterning of hair follicle placodes, while post-
natal inactivation of Notch1 results in almost complete
hair loss, thus indicating that Notch1 is essential for
postnatal hair follicle development and homeostasis
[44].
BMP signaling is also essential, as conditional ablation of
the BMP receptor IA results in hair follicle defects [45].
Mice lacking the BMP inhibitor Noggin show defects in
the function of the canonical Wnt pathway in the hair
follicle [46], suggesting cross talk between the BMP and
the Wnt signaling pathways.
Telomere shortening impairs hair growth by inhibiting
mobilization of stem cells out of their niche. In contrast,
conditional overexpression in mouse skin epithelium of
the catalytic component of telomerase Tert causes pro-
liferation of HFSCs in the bulge, thereby facilitating
robust hair growth through an unconventional mechan-
ism that does not involve the synthesis of telomere
repeats [47,48]. Conditional deletion of Rac1, a nega-
tive regulator of c-Myc, in the adult mouse epidermisrized reproduction of this article is prohibited.
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HFSCs and interfollicular stem cells [49]. Studies are
now awaited to allocate these molecules within the in-
tricate puzzle of the signaling pathways that play a role in
the modulation of stem cell function in the skin.
The mesenchymal stem cell niches
Mesenchymal stem cells (MSCs), conventionally derived
from bone marrow, have the ability to self-renew and to
differentiate into cartilage, bone and adipose tissue at the
single cell level [50]. Their clinical use in orthopedic
applications has been long sought and successfully
achieved for cartilage and bone repair [51]. The lack of
specific cell-surface markers has so far hindered the direct
purification of a highly homogeneous population of
MSCs, which would be desirable to obtain clinical grade,
identity-characterized ‘MSC products’ with consistent
and reproducible efficacy [51]. A reasonable enrichment
of bone marrow MSCs prior to cell culture has been
obtained using combinations of markers [52,53]. Multi-
potent MSCs have also been isolated from other tissues
including periosteum, synovial membrane and synovial
fluid [54–57]. Nonetheless, our knowledge on the MSC
niches within their native tissues is very poor and whether
MSCs are a cell culture artifact is a fundamental unre-
solved issue. It has been suggested that MSCs harbor in
perivascular areas in the bone marrow [58], where they
may be in close proximity to HSCs. The inhibitory effect
of MSCs on cell proliferation in vitro [59] raises the
attractive possibility of a role of MSCs in the maintenance
of HSC quiescence. Intriguingly, following intramedul-
lary transplantation into the bone marrow of immuno-
deficient mice, human MSCs differentiated into peri-
cytes, stromal cells, bone-lining osteoblasts, and endo-
thelial cells, all functional components of the marrow
hematopoietic microenvironment [60].
In the adult articular cartilage the superficial layer may
function as a niche as it contains highly clonogenic multi-
potent cells that express Notch1 [61]. Compelling evi-
dence is awaited, however.
Niches and stem cell divisions
Under homeostatic conditions stem cells self-renew and
produce differentiated progeny. An individual stem cell
can give rise to two identical daughter cells (symmetric
division) or to two nonidentical daughter cells, one main-
taining the stem-cell identity and the other becoming a
differentiated cell (asymmetric division). The orientation
of the cleavage plane during stem cell mitosis appears to
have a crucial role in determining symmetric or asym-
metric division, as demonstrated in invertebrate model
systems [3,62,63]. When the stem cell divides with a
cleavage plane perpendicular to the niche cell, both
daughter cells remain in contact with the niche cell; in
contrast, when the stem cell divides with a cleavage planeopyright © Lippincott Williams & Wilkins. Unauthparallel to the niche cell, then only one daughter cell
remains in contact with the niche cell while the other is
displaced away from the niche to relocate into a differ-
entiation-promoting microenvironment [3,62,63]. In
asymmetric cell division, an unequal segregation of
specific cell-fate determinants between the two daughter
cells has been well documented in invertebrate animals
[64,65,66]. Evidence for asymmetric cell division in
mammalian stem cell systems has recently been provided
for the basal cells of the skin epidermis [67].
Stem cell niches and cancer
Niche structures appear to have the potential to enforce
stem cell-like characteristics on nonstem cell types. Stu-
dies in invertebrates have shown that nonstem cell types
may engage a vacant niche, reverting to a stem cell-like
state [68,69]. The same could hold true in mammals,
since in mice melanocyte stem-cell progeny migrates out
of the niche, amplifies outside the niche and can then
repopulate vacant niches, eventually returning to the
quiescent state of stem cells [70]. Thus, there is the
theoretical possibility that niches may be capable of
contributing to abnormal tissue regulation, encouraging
malignant cells by providing stem-like features to a more
mature cell type. On the other hand, tumor cells appear
to have the ability to establish favorable niches for
metastasis [71].
Niches prevent stem cell expansion [5,6]. Unregulated
expansion of self-renewing stem cells could lead to tumor
formation. Indeed, a subset of cancer cells within tumors,
named cancer stem cells, may drive the growth and
metastasis of these tumors [72]. The presence of a stem
cell population in a tumor has clinical implications, as
cancer stem cells would become the target for diagnosis
and treatment. Recent studies indicate that compromised
inheritance of cell-fate determinants contributes to
unrestrained growth of the mutant neuroblast lineage
in Drosophila via upregulation of specific target genes
that control cell cycle, suggesting a mechanism by which
loss of polarity in stem cells may lead to tumorigenesis
[65,73,74]. Thus, correct regulation of stem-cell self-
renewal requires a tight control of the re-distribution of
cell-fate determinants between the two daughter cells
during mitosis.
Conclusion
Advancement in our knowledge of the stem cell niches
nourishes hopes of niche manipulations for therapeutic
purposes to modify stem cell outcomes clinically. Thus,
considerable attention is now directed to the niche cells
and to their molecular signals to control stem cells. Mol-
ecular analyses of purified niche cells to determine their
signaling repertoire have just started [75]. These studies
will help depict a comprehensive picture of the niche-
orchestrated biological functions by understanding howorized reproduction of this article is prohibited.
C402 Basic sciencesignals in the niches are coupled to events such as cell-
cycle regulation and distinct transcriptional programs. In
addition, they will allow the development of in-vitro
systems that reproduce the in-vivo niches. The establish-
ment of validated ‘in-vitro niches’ will enable systematic
analyses of the molecular and cellular interactions at the
niche sites as well as high throughput screenings of com-
pounds affecting niche biology and outcomes. This will
help investigate how niches are altered in situations of
stress or pathology, such as cancer. The elucidation of the
niche biology in health and disease has thus become a
pressing issue in basic science and medicine. Such knowl-
edge could lead to changes in established clinical mea-
sures; for instance, agents developed to target osteoblasts
for bone disorders such as osteoporosis will have to be re-
assessed for their effects on HSC physiology. It will also
instruct the development of novel therapies. The growing
availability of small compounds to target signaling path-
ways even in a tissue/cell-specific fashion as well as of
controlled delivery systems makes the molecular manip-
ulation of the stem cell niche an attractive alternative to
stem cell therapy to achieve tissue repair and re-establish
tissue homeostasis. This would circumvent current limita-
tions of the stem cell-based protocols associated with in-
vitro cell-culture expansion, such as genetic and pheno-
typic instability, disease transmission, high costs, and
variability [51].
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